You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Adverse events

From: Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-

   Grade
   1 2 3 4 3/4
Hematological       
Leukocytopenia Level 1 (n = 3) 1 0 0 0 0
  2 (n = 3) 1 0 1 0 1
  3 (n = 3) 1 0 0 0 0
Neutropenia 1 0 0 0 0 0
  2 0 0 1 0 1
  3 1 0 0 0 0
Anemia 1 0 0 0 0 0
  2 0 0 1 0 1
  3 0 0 0 0 0
Thrombocytopenia 1 1 0 1 0 1
  2 2 0 0 0 0
  3 0 2 0 0 0
Nonhematological       
Nausea 1 0 1 0 0 0
  2 0 0 0 0 0
  3 1 0 1* 0 1
Diarrhea 1 0 0 0 0 0
  2 0 0 0 0 0
  3 0 0 1* 0 1
AST/ALT elevation 1 1 0 0 0 0
  2 2 0 0 0 0
  3 1 0 0 0 0
Bilirubin elevation 1 1 1 0 0 0
  2 0 1 0 0 0
  3 1 0 0 0 0
Creatinin elevation 1 1 0 0 0 0
  2 0 0 0 0 0
  3 1 0 0 0 0
  1. *: Dose-limiting toxicity, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase.